
Dermatology
Latest News
Latest Videos

CME Content
More News

A new cohort shows FLG loss-of-function variations are often different among AD pediatric patients with different ancestries.

After a decade-plus, the risk management reduction program is not associated with a direct drop in at-risk pregnancies.

A recent study examined the relationship between different types of infection and incidence of stroke.

After showing the ability to regain patients' senses of smell and taste in a pair of phase 3 trials, the biologic becomes the first indicated for CRSwNP.

Both brick-and-mortar dermatology clinics as well as telehealth programs are limited and restricted by barriers to access.

Patients on 2 different doses of the once-daily oral JAK1 inhibitor reached statistically significant measures for improved symptoms.

Patients diagnosed with psoriasis face a nearly three-fold greater risk of developing anxiety disorders.

Both parents and children with atopic dermatitis often lack answers when it comes to the possibility that food allergies might be causing their skin irritations.

Marketed sunscreen in the US is a bit more regulated than in other countries. But are those regulations helpful?

A new NIH-funded study showed that patients with atopic dermatitis may increase their risk of food allergies when they scratch their skin.

A new study from Canada found children as young as 9 months of age can safely undergo the desensitization treatment routinely.

The lotion, Duobrii, combines halobetasol propionate, a topical steroid, with tazarotene, a retinoid, to provide 2 mechanisms of action for treating plaque psoriasis.

An assessment of the world's largest twin registry found telling patterns of common autoimmune diseases including type 1 diabetes.

There are currently no FDA-approved prescription treatments for common warts, instead dermatologists must rely on painful alternatives like cutting, burning, and freezing.

Following the completion of 2 pivotal trials, a new drug application for VP-102 will be submitted later this year.

An examination of the physical, emotional and social burden of psoriasis, and the continued need for research to advance care for patients.

Onychomycosis—fungal infection of the nail—is a common medical problem. Treatments are widely available, but relapse is common.

This is the third indication for the biologic therapy, following its approvals for adult AD and moderate to severe asthma maintenance care.

In a post hoc analysis, Green and colleagues examined the effect of halobetasol and tazarotene lotion on plaque psoriasis in a Hispanic population.

Green introduces the combination lotion tested in this clinical trial of patients with moderate-to-sever plaque psoriasis.

Recommendations for acne treatment drawn from AAD position paper and presentations.

The biologic has been previously approved for adult atopic dermatitis and uncontrolled asthma, and is being assesed for another half-dozen allergic/immunologic indications.

Even in trials like UltIMMA that compare 2 drugs, a placebo control grounds the data, says Ken Gordon, MD.

The nodular acne therapy has been a staple treatment for 3 decades, yet new AAD data showed it could still be better utilized in patients.

Confocal microscopy is especially useful for diagnosing pigmented lesions, moles, melanoma, and basal cell carcinoma.

































































